LGND vs AAPL: Which Stock is Better?

Side-by-side comparison of Ligand Pharmaceuticals Inc and Apple Inc in 2026

Comparison Updated:

LGND

Ligand Pharmaceuticals Inc

$231.82

AAPL

Apple Inc

$269.84

Key Metrics Comparison

MetricLGNDAAPLWinner
Market Cap$4.62BN/ALGND
P/E Ratio37.8233.32AAPL
EPS (TTM)$6.13$8.11AAPL
Revenue Growth0.4%0.2%LGND
Gross Margin64.3%47.3%LGND

Analyze LGND

Full quant analysis

Analyze AAPL

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is LGND or AAPL a better investment?

Comparing LGND and AAPL: Ligand Pharmaceuticals Inc has a market cap of $4.62B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between LGND and AAPL?

LGND (Ligand Pharmaceuticals Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: LGND or AAPL?

Based on P/E ratios, AAPL trades at a lower multiple (33.3x vs 37.8x).

Which is growing faster: LGND or AAPL?

LGND has higher revenue growth at 0.4% vs 0.2% for AAPL.

Which company is more profitable: LGND or AAPL?

Ligand Pharmaceuticals Inc (LGND) has higher gross margins at 64.3% compared to 47.3% for AAPL.

Which is the larger company: LGND or AAPL?

Ligand Pharmaceuticals Inc (LGND) is larger with a market cap of $4.62B compared to N/A for AAPL.

Should I buy LGND or AAPL in 2026?

Both LGND and AAPL have investment merit. LGND trades at $231.82 while AAPL trades at $269.84. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between LGND and AAPL stock?

Key differences: Market Cap ($4.62B vs N/A), P/E Ratio (37.8x vs 33.3x), Revenue Growth (0.4% vs 0.2%), Gross Margin (64.3% vs 47.3%).

Popular Stock Comparisons